Clinical effects of actarit in rhemnatoid arthritis: Improvement of early disease activity mediated by reduction of serum concentrations of nitric oxide

Clinical and Experimental Rheumatology

Volumn 18, Issue 4, 2000, Pages 445-450

  Nakamura, H ^a   Ueki, Y ^a   Sakito, S ^a   Matsumoto, K ^a   Yano, M ^a   Miyake, S ^a   Tominaga, Y ^a   Eguchi, K ^a  

^a SASEBO CHUO HOSPITAL   (Japan)

Author keywords

Actarit; Cytokines; NO; Rheumatoid arthritis

Indexed keywords

ACTARIT; AURANOFIN; BIOCHEMICAL MARKER; BUCILLAMINE; C REACTIVE PROTEIN; METHOTREXATE; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PREDNISOLONE; SALAZOSULFAPYRIDINE; TIOPRONIN;

ADULT; ARTHRALGIA; ARTICLE; BLOOD LEVEL; CHEMOLUMINESCENCE; CLINICAL ARTICLE; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG EFFECT; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GRIP STRENGTH; HUMAN; MALE; MORNING STIFFNESS; PAIN ASSESSMENT; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CHEMILUMINESCENT MEASUREMENTS; FEMALE; HEMOGLOBINS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; NITRIC OXIDE; PHENYLACETATES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0033863754     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Role of endothelium in chronic inflammatory synovitis
2. Trends in the use of disease modifying antirheumatic medications in rheumatoid arthritis, 1980-1995: Results from the National ambulatory medical care surveys
3. Characterization of suppresser cells activated by 4-acetylaminophenylacetic acid (MS-932) on delayed-type hypersensitivity
4. Effect of MS-932 (4-acetylaminophenylacetic acid) on articular lesion in MRL/I mice
5. One-year clinical resuits with actarit-a preliminary report
6. Nonspecific defense mechanism: The role of nitric oxide
7. Nitric oxide: Physiology, pathophysiology, and pharmacology
8. Increased nitric oxide levels in patients with rheumatoid arthritis
9. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
10. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire
11. Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients: Possible involvement in joint destruction
12. Serum cytokines in patients with rheumatoid arthritis
13. Induction of nitric oxide synthase gene by interleukin in vascular smooth muscle cells
14. Effects of actarit on synovial cell functions in patients with rheumatoid arthritis
15. Stimulation of lymphocyte natural cytotoxicity by L-arginine
16. Selective inhibition of endothelium-dependent relaxation by gold-containing compounds
17. Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell haemoglobin
18. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
19. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases
20. Estimation of dietary intake of nitrate and nitrite in Great Britain
21. 15N) nitrate in biological fluids